Homozygous Familial Hypercholesterolemia (HoFH) – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
Homozygous familial hypercholesterolemia (HoFH) is a genetic disorder that causes severe elevations in low-density lipoproteins cholesterol (LDL-C) and total cholesterol. Those with HoFH have a very high chance of premature coronary artery disease. Familial hypercholesterolemia is a deficiency or absence of the LDL-C receptors. It can also be caused by mutations of the apolipoprotein B-100 (apoB-100) binding site on LDL-C receptors, PCSK9, and LDLRAP1. The LDLR gene is located on the short arm of chromosome 19.6 LDL-C receptors are responsible for about 70% of the uptake of circulating LDL-C molecules into the liver. Reductions in the number of LDL-C receptors lead to an accelerated deposition of cholesterol on the walls of arteries. The arteries then harden and narrow and reduce the flow of blood. This reduction in blood flow can lead to cardiovascular diseases like stroke and myocardial infarction. · In the year 2020, the estimated prevale...